Low infectivity but high mortality: strategies to minimise spread until the vaccine arrives are the key
Hendra virus (HeV) infection in humans is an emerging zoonotic disease that has a high mortality rate, but low infectivity. In all cases to date, the infection has been transmitted to humans from bats of the genus Pteropus (flying foxes) via an intermediate equine host.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Wang L, Harcourt BH, Yu M, et al. Molecular biology of Hendra and Nipah viruses. Microbes Infect 2001; 3: 279-297.
- 2. Selvey LA, Wells RM, McCormack JG, et al. Infection of humans and horses by a newly described morbillivirus. Med J Aust 1995; 162: 642-645. <MJA full text>
- 3. Paterson DL, Murray PK, McCormack JG. Zoonotic disease in Australia caused by a novel member of the paramyxoviridae. Clin Infect Dis 1998; 27: 112-118.
- 4. Playford EG, McCall B, Smith G, et al. Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008. Emerg Infect Dis 2010; 16: 219-223.
- 5. Hanna JN, McBride WJ, Brookes DL, et al. Hendra virus infection in a veterinarian. Med J Aust 2006; 185: 562-564. <MJA full text>
- 6. McCormack JG, Allworth AM, Selvey LA, Selleck PW. Transmissibility from horses to humans of a novel paramyxovirus, equine morbillivirus (EMV). J Infect 1999; 38: 22-23.
- 7. Ward MP, Black PF, Childs AJ, et al. Negative findings from serological studies of equine Morbillivirus in the Queensland horse population. Aust Vet J 1996; 74: 241-243.
- 8. Middleton D. Initial experimental characteristics of HeV (Redland Bay 2008) infection in horses. Canberra: Commonwealth Scientific and Industrial Research Organisation, 2009. http://www.dpi.qld.gov.au/documents/Biosecurity_GeneralAnimalHealthPestsAndDiseases/HeV-Initial-experimental-characterisation.pdf (accessed Aug 2011).
- 9. Selvey LA, Taylor R, Arklay A, Gerrard, J. Screening of bat carers for antibodies to equine Morbillivirus. Commun Dis Intell 1996; 20: 477-478.
- 10. Westbury HA, Hooper PT, Selleck PW, Murray PK. Equine morbillivirus pneumonia: susceptibility of laboratory animals to the virus. Aust Vet J 1995; 72: 278-279.
- 11. Field H, Young P, Yob JM, et al. The natural history of Hendra and Nipah viruses. Microbes Infect 2001; 3: 307-314.
- 12. Edmondston J, Field H. Research Update: Hendra Virus. Melbourne: Australian Biosecurity CRC for Emerging Infectious Disease, 2009. http://www1.abcrc.org.au/uploads/8aee9ac0-1355-4339-b5b6-5772a4ee6cf7/docs/HeV_Review_updated170909.pdf (accessed Aug 2011).
- 13. Bossart KN, Zhu Z, Middleton D, et al. A neutralising human monoclonal antibody protects against lethal disease in a new ferret model of acute Nipah virus infection. PLoS Pathog 2009; 5: e1000642.
- 14. McEachern JA, Bingham J, Crameri GS, et al. A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats. Vaccine 2008; 26: 3842-3852.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
No relevant disclosures.